1. Balkwill FR (1989) Interferons. Lancet 8646: 1060–1063
2. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE (1991) Shedding of ICAM-i from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor- alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 147: 4398–4401
3. Becker JC, Winkler B, Klingert S, Brocker EB (1994) Antiphospholipid Syndrome associated with immunotherapy for patients with melanoma. Cancer 73: 1621–1624
4. Böni R, Dummer R, Burg G (1995) Systemic sclerosis and leukoderma induced by Il2- and IFN-alpha therapy in a melanoma patient. Eur J Dermatol (in press)
5. Davis-Daneshfar A, Dummer R, Böni R, Wussow P von, Joller H, Burg G (submitted) Adjuvant immunotherapy in malignant melanoma: Formation of antibodies against recombinant Interferon-alpha.